Revised October 2006:

• Influenza protocol (see link below)
• Clostridium difficile-Associated Diseases (CDAD)

Revised - July 31, 2006:

West Nile virus -

• Public Health Human Case Investigation Form (revised)
• Public Health Human Case Investigation Protocol (revised)

Introduction:  Purpose of the Manual

The prevention, management and control of communicable diseases requires the active participation and cooperation of all health-care professionals and practitioners.  With increasing scientific knowledge and the various approaches used to deliver health services, our collective response to newly identified and evolving pathogens must be routinely reviewed and amended.

This manual is intended to be a guide to the management and control of communicable diseases within the Province of Manitoba.  It is not intended to be a "how-to" book.  Actual approaches to the direct provision of care and services will be determined and implemented by those charged with providing care and services.

Epidemiologic information about each illness or condition is presented with reference to provincial and national trends.  Detailed information related to laboratory testing, treatment, and investigation is included and reflects current clinical and public health knowledge as well as current laboratory and public health practices and policies.

Table of Contents

To view the following Adobe Acrobat PDF files, you need to have at least version 4.0 or higher of the Adobe Acrobat Reader installed on your computer.  To obtain a free copy, or upgrade from version 3.0, please click here:

Introduction

• Diseases and Dead Bodies Regulations
• Communicable Disease Surveillance
• Epidemiological Investigation of Outbreaks
• Control of Enteric Infections
• Diseases Reportable by Health Professionals (HP) and Laboratories (L)
• Maladies devant être déclarées par les professionnels de la santé (PS) et les laboratoires (L)
• Manitoba Provincial Outbreak Response Plan (ORP)

Amebiasis

Anthrax

Botulism

Brucellosis

Campylobacter Infection

Cervicitis

Chancroid

Children with Sexually Transmitted Diseases (STDs)

Chlamydia trachomatis Infection

• Chlamydia – A Sexually Transmitted Infection
• La chlamydiose est une maladie transmissible sexuellement

Cholera

Clostridium difficile-Associated Diseases (CDAD)

Congenital/Neonatal H. Simplex Infection

Creutzfeldt-Jakob Disease (CJD)

Cryptosporidiosis

• Cryptosporidium Infection
• Infection au Cryptosporidium

Cytomegalovirus Infection

Diphtheria

• Td Vaccine to Prevent Tetanus and Diphtheria
• Vaccin Td ou antitétanique et antidiphthérique

Genital Herpes

Genital Warts

Giardiasis

Gonorrhea

• Gonorrhea – A Sexually Transmitted Infection
• La gonorrhée est une maladie transmissible sexuellement

Group B Streptococcal Disease of the Newborn

Haemophilus influenzae B Invasive Disease

• HIB Vaccine for Haemophilus influenzae type b
• Vaccin contre l’Haemophilus influenzae de sérotype b
• Haemophilus influenzae Disease

Hantavirus Infection Pulmonary Syndrome

• Hantavirus Infection
• Infection au hantavirus
• Hantavirus Infection Pulmonary Syndrome

Hepatitis A

Hepatitis B

• Hepatitis B Vaccine
• L'immunisation contre l'hépatite B

Hepatitis C

• Hepatitis C: Information for Physicians, Public Health Nurses and Other Health Professionals

Human Immunodeficiency Virus (HIV) Infection and the Acquired Immunodeficiency Syndrome (AIDS)

Influenza

• Influenza Fact Sheet
• Renseignements sur la grippe

Invasive Group A Streptococcal Necrotizing Fasciitis, Necrotizing Myositis and Toxic Shock Syndrome

• Information for Physicians on Invasive Group A Streptococcal Necrotizing Fasciitis, Necrotizing Myositis and Toxic Shock Syndrome
• Necrotizing Fasciitis ("Flesh-eating Disease")
• Fasciite nécrosante (« maladie dévoreuse de chair »)

Legionellosis

Leprosy

Listeriosis

Lyme Disease

• Lyme Disease:  Information for Health Professionals
• What You Should Know About Lyme Disease
• Ce qu’il faut savoir sur la maladie de Lyme

Malaria

Measles (Rubeola, Hard measles, Red measles, Morbilli)

• Measles/Rubella (MR)
• Vaccin antirougeoleux et antirubéoleux (RR)
• Measles/Mumps/Rubella (MMR)
• Vaccin associé Rougeole-Oreillons-Rubéole (ROR)

Meningococcal Invasive Disease

• What You Should Know About Ciprofloxacin (or Cipro)
• Ce qu’il faut savoir au sujet de la ciprofloxacine (ou cipro)
• Meningococcal Infections
• Letter to Public Health Staff (revised December 2005)
• Important Notes on Rifampin (Also known as Rifadin, Rimactane, Rifampicin, Rofact)
• Meningococcal Rifampin Dosage Table (For children more than one (1) month and adults)
• Meningococcal Contact Form (revised December 2005)
• Control and Prevention of Serogroup C Meningococcal Disease:  Evaluation and Management of Suspected Outbreaks:  Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Methicillin and Vancomycin Resistant Staphylococcus aureus (MRSA/VRSA) Infection

• What You Should Know About Methicillin Resistant Staphylococcus aureus (MRSA)
• Ce qu’il faut savoir au sujet du staphylocoque doré résistant à la méthicilline (S.D.R.M.)
• Infection Control Guidelines for Health Care Workers in the Community
• Methicillin-Resistant Staphylococcus aureus (MRSA) Infection Control Guidelines for Manitoba

Molluscum Contagiosum

Mumps

Parvovirus B19 Infection (Fifth Disease)

Pediculosis (Head, Body or Crab Lice)

• Head Lice Control Check List
• Liste de vérification en cas d’infestation de poux de tête
• Head Lice
• Poux de tête

Pertussis/Parapertussis

• DaPTP/Hib Vaccine for Diphtheria, Pertussis, Tetanus, Polio, Hib
• DaPTP Vaccine to Prevent Diphtheria, Pertussis, Tetanus, Polio

Plague

• Recommended Guidelines for Suspected Plague Cases at Winnipeg International Airport

Poliovirus Infections

• OPV to IPV Conversion Schedule
• VPTO au VPTI calendrier adapté

Psittacosis

Rabies

• Protocol for Management of Animal Exposures to Prevent Human Rabies
• Rabies Fact Sheet
• Collection and Shipping of Samples for Laboratory Testing for Rabies

Respiratory Syncytial Virus Infection (RSV)

Rubella (German Measles)

• Measles/Rubella (MR)
• Vaccin antirougeoleux et antirubéoleux (RR)
• Measles/Mumps/Rubella (MMR)  
• Vaccin associé Rougeole-Oreillons-Rubéole (ROR)
• Rubella Fact Sheet

Salmonellosis (Non-Typhoid)

Scabies

Sexually Transmitted Enteric Infections

Shigellosis

Staphylococcal Food Intoxication

Streptococcus pneumoniae (Pneumococcus) Invasive Infections

Syphilis

Tetanus

• Tdap Vaccine:  Tetanus, Diphtheria, Acellular Pertussis
• Vaccin dTCa (diphtérie, tétanos et coqueluche acellulaire)
• DaPTP/Hib Vaccine to Prevent Diphtheria, Pertussis, Tetanus, Polio, Haemophilus influenzae type B
• Le vaccin DCaTP-Hib pour prévenir la Diphtérie, la Coqueluche, le Tétanos, la Polio, Haemophilus influenzae de type B
• DaPTP Vaccine to prevent Diphtheria, Pertussis, Tetanus, Polio
• Le vaccin DCaTP pour prévenir la Diphtérie, la Coqueluche, le Tétanos et la Polio Toxoplasmosis

Toxoplasmosis

Trichinosis

Tuberculosis

• Tuberculosis (TB)
• Tuberculose
• Important Notes on Rifampin (Also known as Rifadin, Rimactane, Rifampicin, Rofact)

Tularemia

• Information for Health Care Professionals

Typhoid and Paratyphoid Fever

Urethritis

Vancomycin Resistant Enterococci (VRE)

• What You Should Know About Vancomycin Resistant Enterococci (VRE)
• Ce qu’il faut savoir au sujet des entérocoques résistants à la vancomycine (ERV)
• Infection Control Guidelines for Health Care Workers in the Community
• Manitoba Infection Control Guidelines for Preventing the Spread of Vancomycin-Resistant Enterococci (VRE) (Long-Term care Facilities)
• Manitoba Infection Control Guidelines for Preventing the Spread of Vancomycin-Resistant Enterococci (VRE) (Acute Health-care Facilities)

Varicella/Herpes Zoster (Chickenpox/Shingles)

Verotoxigenic E. coli (VTEC) Infection

Viral Meningitis/Encephalitis

West Nile virus Public Health Human Case Investigation Form

West Nile virus Public Health Human Case Investigation Protocol

Yellow Fever

Yersiniosis

• Oseltamivir (Tamiflu™) for Institutional Outbreak Control
• Integrated Post-Exposure Protocol Guidelines for Managing Exposures to Blood/Body Fluids
• Counselling Guidelines for Clients with Accidental Exposure to Blood or Body Fluids
• Information for Individuals Who May Have Been Exposed to HIV, the AIDS Virus
• Manitoba Immunization Schedule
• Thimerosal in Vaccines
• PEP Letter (added December 2005)
• Protocol for Management of Suspected Anaphylactic Shock in Non-Hospital Settings
• What You Should Know About Blastomycosis
• Ce que vous devriez savoir à propos de la blastomycose
• Sexually Transmitted Diseases Treatment Guidelines (revised December 2005)
• Instructions for STD Medication Administration Form
• STD Medication Administration Form
• STD Transition Letter (added December 2005)
• International Travel

• Report of Communicable Diseases
• Communicable Disease Control Investigation Form
• Notification of Sexually Transmitted Disease
• Viral Hepatitis Investigation Form (Hepatitis B and Hepatitis C)
• HIV/AIDS Case Report
• Notification of HIV Infection
• PEP Manitoba Health Order Form (added December 2005)
• PEP WRHA Order Form (added December 2005)
• Report of a Vaccine-Associated Adverse Event
• Blastomycosis Laboratory-Based Surveillance
• Phone Report of Possible Rabies Exposure
• Outbreak Report
• STD Medication Order Form (revised December 2005)
• Information Record:  HIV Post-Exposure Prophylaxis

Communicable Disease Control (CDC) Unit  Public Health Branch Manitoba Health 4th Floor - 300 Carlton St. Winnipeg MB  R3B 3M9  CANADA Phone: (204) 788-6737 Fax: (204) 948-2040	Visit our Healthy Living website for more information on many of these topics.